A national therapeutic committee is critically appraising four recently published clinical studies to update clinical practice guidelines. Each study's supplemental methodology section reveals specific design choices or execution flaws. Identify the primary epidemiological bias or statistical phenomenon that characterizes each study's description.
- Study 1 (Novel Anticoagulant): Over the 2-year follow-up, 18% of patients in the investigational arm withdrew due to nuisance bruising, compared to 2% in the control arm, prior to ascertainment of the primary ischemic stroke outcome.Attrition bias (differential loss to follow-up)
- Study 2 (Immunosuppressant): A retrospective database analysis showed higher rates of asymptomatic bacteriuria in patients on the new drug. Protocol mandated monthly urinalyses for this group, whereas the standard therapy group received annual screening.Surveillance bias (differential outcome ascertainment)
- Study 3 (GLP-1 Agonist): An observational cohort study found worse baseline renal function and significantly longer diabetes duration in patients prescribed the novel agent compared to those maintained on older oral therapies.Confounding by indication (treatment assignment linked to disease severity)
- Study 4 (Targeted Oncology Agent): A Phase III trial was halted prematurely for overwhelming efficacy at the first interim analysis after only 25 progression events occurred, reporting a progression-free survival hazard ratio of 0.22.Overestimation of treatment effect (random high from early termination)
Answer
Study 1 demonstrates Attrition bias; Study 2 demonstrates Surveillance bias; Study 3 demonstrates Confounding by indication; Study 4 demonstrates Overestimation of treatment effect.
Matching these methodological descriptions to their respective biases requires understanding how study design flaws manifest in clinical literature. Study 1 describes differential loss to follow-up, which is the definition of attrition bias, threatening internal validity. Study 2 demonstrates surveillance bias (detection bias), as the group undergoing more frequent testing is artificially more likely to have asymptomatic conditions detected. Study 3 illustrates confounding by indication, a common issue in observational studies where the choice of treatment is heavily influenced by the patient's underlying disease severity. Study 4 highlights the danger of early termination for benefit with a low number of events; trials stopped early often overestimate the true treatment effect due to random statistical highs.
Step-by-Step Solution
Key Concept
Critical appraisal of medical literature requires identifying specific methodological flaws that threaten study validity, such as differential loss to follow-up, unequal screening practices, baseline prognostic imbalances, and the statistical perils of early termination.